biostudies-literatureUnknown27(Suppl 2)Vincent PAnnals of oncology : official journal of the European Society for Medical Oncologyii83-ii84https://www.ebi.ac.uk/biostudies/studies/S-EPMC4984073biostudies-literatureP-286Metronomic 5-fluorouracil (5-FU) plus nab-paclitaxel (nab-P), bevacizumab, leucovorin, and oxaliplatin (FABLOx) in patients with metastatic pancreatic cancer (MPC): an open-label, multicenter, single-arm, phase 1/2 studyPMC4984073Vaibhav SWasif SPhilip PDiane SAparna KCaio RAllyson OVictoria MVincent PMichael OJack SfalseP-286Metronomic 5-fluorouracil (5-FU) plus nab-paclitaxel (nab-P), bevacizumab, leucovorin, and oxaliplatin (FABLOx) in patients with metastatic pancreatic cancer (MPC): an open-label, multicenter, single-arm, phase 1/2 study2016-01-01T00:00:00Z2016 Jun2025-04-26T20:35:11.766Z2025-04-06T16:26:33.942ZS-EPMC4984073